Recently, pathogenic variants in exons 5 and 6 of ACTB have been reported in six patients presenting with clinical symptoms different from BWCFF, particularly thrombocytopenia which is caused by inhibited platelet maturation as a result of a compromised microtubule organization (49). Here, ACTB is linked to Thrombocytopenia.